Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3/5

CSL (CSL AT)

1
Analysis
Health CareUnited States
CSL Limited develops, manufactures, and markets human pharmaceutical and diagnostic products derived from human plasma. The Company provides products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
bullishCSL Ltd
20 Jun 2025 06:21

CSL Ltd (CSL AU): First In-House Antibody Drug Gets US Approval; Has Blockbuster Potential

​CSL's Andemry receives FDA approval for HAE, and is set to mainly compete with blockbuster drug Takhzyro, with convenience and efficacy edge. CSL...

Logo
299 Views
Share
bullishCSL Ltd
12 Feb 2025 00:30

CSL Ltd (CSL AU): Weak Vaccine Sales Affect H1FY25 Performance; FY25 Guidance Maintained

​CSL Ltd's H1FY25 net profit rises 6% YoY to $2.01B, missing estimates. Revenue is up 5% YoY to $8.48B. FY25 profit guidance reaffirmed at $3.2...

Logo
332 Views
Share
bullishCSL Ltd
22 Oct 2024 12:52Broker

CSL Limited (CSL): Margin Recovery to Drive Earnings

Behring is CSL’s largest division (72% of revenue) and we expect it will continue to do the heavy lifting in the near-term, both in topline growth...

Logo
297 Views
Share
bullishSantos Ltd
10 Jul 2025 07:00Syndicated
Logo
FNArena
152 Views
Share
bullishDroneShield Ltd
03 Jul 2025 06:01Syndicated

Rudi's View: Charter Hall, Droneshield, Pinnacle, WiseTech & More

Update on changes to and revisions of analysts' Best Ideas and Conviction Calls, as well as Model Portfolio compositions

Logo
FNArena
184 Views
Share
x